Generic Eculizumab

Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;κ antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.


Eculizumab Adverse Effects [FDA Report]

Eculizumab side effect


Synonyms
  • 5G1.1

Eculizumab Chemical

Not Available

Brand Names related Eculizumab